$CLDX 8-K SEC Filings

Filed On	Filing
22 Sep 2026	8-K: Other Events Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints
06 Aug 2026	8-K: Results of Operations and Financial Condition
15 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
26 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
07 May 2026	8-K: Results of Operations and Financial Condition
02 Apr 2026	8-K: Entry into a Material Definitive Agreement; Other Events
25 Feb 2026	8-K: Results of Operations and Financial Condition
10 Nov 2025	8-K: Results of Operations and Financial Condition
19 Aug 2025	8-K: Other Events
07 Aug 2025	8-K: Results of Operations and Financial Condition
06 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition
27 Feb 2025	8-K: Results of Operations and Financial Condition
06 Nov 2024	8-K: Results of Operations and Financial Condition
08 Aug 2024	8-K: Results of Operations and Financial Condition
14 Jun 2024	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
06 May 2024	8-K: Results of Operations and Financial Condition
01 Mar 2024	8-K: Entry into a Material Definitive Agreement; Other Events
26 Feb 2024	8-K: Results of Operations and Financial Condition
08 Nov 2023	8-K: Entry into a Material Definitive Agreement; Other Events

Comments